Oculis Holding AG (OCS) Profit After Tax (2022 - 2026)
Oculis Holding AG (OCS) recorded quarterly Profit After Tax of -$36.8 million in Q1 2026, down 25.23% quarter-over-quarter from -$29.4 million in Q4 2025, and little changed on a YoY basis from -$36.7 million in Q1 2025.
Oculis Holding AG (OCS) Profit After Tax (2022 - 2026) Analysis & Trends
Oculis Holding AG's Profit After Tax history runs 5 years deep, the most recent figure standing at -$36.8 million for Q1 2026.
- In Q1 2026, Profit After Tax changed 0.26% year-over-year to -$36.8 million; the TTM figure through Mar 2026 stood at -$21.2 billion (up 9.53% YoY), while the FY2025 annual figure was -$123.8 million, down 26.45% from the prior year.
- Profit After Tax was -$36.8 million for Q1 2026 at Oculis Holding AG, down from -$29.4 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$9.5 million in Q4 2022 to a low of -$23.3 billion in Q3 2024.
- Historically, Profit After Tax has averaged -$2.8 billion across 5 years, with a median of -$26.2 million in 2025.
- Biggest YoY gain for Profit After Tax was 62.94% in 2024; the steepest drop was 118106.55% in 2024.
- A 5-year view of Profit After Tax shows it stood at -$9.5 million in 2022, then tumbled by 47.82% to -$14.1 million in 2023, then sank by 132.14% to -$32.7 million in 2024, then rose by 10.06% to -$29.4 million in 2025, then decreased by 25.23% to -$36.8 million in 2026.
- The last three Profit After Tax figures came in at -$36.8 million (Q1 2026), -$29.4 million (Q4 2025), and -$21.1 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -56.74 Mn |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - | -36.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.84 Mn |
| Dec 31, 2025 | -29.42 Mn |
| Sep 30, 2025 | -21.07 Bn |
| Jun 30, 2025 | -30.65 Mn |
| Mar 31, 2025 | -36.94 Mn |
| Dec 31, 2024 | -32.71 Mn |
| Sep 30, 2024 | -23.30 Bn |
| Jun 30, 2024 | -23.04 Mn |
| Mar 31, 2024 | -18.44 Mn |
| Dec 31, 2023 | -14.09 Mn |
| Sep 30, 2023 | -19.71 Mn |
| Jun 30, 2023 | -14.32 Mn |
| Mar 31, 2023 | -49.75 Mn |
| Dec 31, 2022 | -9.53 Mn |
| Sep 30, 2022 | -10.31 Mn |
| Jun 30, 2022 | -12.82 Mn |